keyword
https://read.qxmd.com/read/38522046/exploring-host-epigenetic-enzymes-as-targeted-therapies-for-visceral-leishmaniasis-in-silico-design-and-in-vitro-efficacy-of-kdm6b-and-ash1l-inhibitors
#21
JOURNAL ARTICLE
Mukul Dutta, Tooba Qamar, Unnati Kushavah, Mohammad Imran Siddiqi, Susanta Kar
In order to combat various infectious diseases, the utilization of host-directed therapies as an alternative to chemotherapy has gained a lot of attention in the recent past, since it bypasses the existing limitations of conventional therapies. The use of host epigenetic enzymes like histone lysine methyltransferases and lysine demethylases as potential drug targets has successfully been employed for controlling various inflammatory diseases like rheumatoid arthritis and acute leukemia. In our earlier study, we have already shown that the functional knockdown of KDM6B and ASH1L in the experimental model of visceral leishmaniasis has resulted in a significant reduction of organ parasite burden...
March 24, 2024: Molecular Diversity
https://read.qxmd.com/read/38513779/a-metabolomics-approach-reveals-metabolic-disturbance-of-human-cholangiocarcinoma-cells-after-parthenolide-treatment
#22
JOURNAL ARTICLE
Yongping He, Qianxue Yu, Xiaoyu Ma, Diya Lv, Hui Wang, Weian Qiu, Xiao Fei Chen, Yang Jiao, Yue Liu
ETHNOPHARMACOLOGICAL RELEVANCE: Tanacetum parthenium (L.) Schultz-Bip, commonly known as feverfew, has been traditionally used to treat fever, migraines, rheumatoid arthritis, and cancer. Parthenolide (PTL), the main bioactive ingredient isolated from the shoots of feverfew, is a sesquiterpene lactone with anti-inflammatory and antitumor properties. Previous studies showed that PTL exerts anticancer activity in various cancers, including hepatoma, cholangiocarcinoma, acute myeloid leukemia, breast, prostate, and colorectal cancer...
March 19, 2024: Journal of Ethnopharmacology
https://read.qxmd.com/read/38512973/protective-effect-of-sucrose-esters-from-cape-gooseberry-physalis-peruviana-l-in-tnbs-induced-colitis
#23
JOURNAL ARTICLE
Yanet C Ocampo, Jenny P Castro, Indira B Pájaro, Daneiva Caro, Elena Talero, Virginia Motilva, Luis A Franco
Phytotherapy is an attractive strategy to treat inflammatory bowel disease (IBD) that could be especially useful in developing countries. We previously demonstrated the intestinal anti-inflammatory effect of the total ethereal extract from the Physalis peruviana (Cape gooseberry) calyces in TNBS-induced colitis. This work investigates the therapeutic potential of Peruviose A and B, two sucrose esters that constitute the major metabolites of its calyces. The effect of the Peruvioses A and B mixture on TNBS-induced colitis was studied after 3 (preventive) and 15-days (therapy set-up) of colitis induction in rats...
2024: PloS One
https://read.qxmd.com/read/38501503/fortunellin-ameliorates-lps-induced-acute-lung-injury-inflammation-and-collagen-deposition-by-restraining-the-tlr4-nf-%C3%AE%C2%BAb-nlrp3-pathway
#24
JOURNAL ARTICLE
Danjuan Liu, Rongjie Guo, Bingbing Shi, Min Chen, Shuoyun Weng, Junting Weng
OBJECTIVE: Acute lung injury (ALI) is the prevalent respiratory disease of acute inflammation with high morbidity and mortality. Fortunellin has anti-inflammation property, but its role in ALI remains elusive. Thus, this study clarified the function of fortunellin on ALI pathogenesis. METHODS: The ALI mouse model was established by lipopolysaccharide (LPS) induction, and lung tissue damage was evaluated utilizing hematoxylin-eosin (HE) staining. The edema of lung tissue was measured by the lung wet/dry (W/D) ratio...
March 2024: Immunity, Inflammation and Disease
https://read.qxmd.com/read/38494644/linker-based-pharmacophoric-design-and-semisynthesis-of-labdane-conjugates-active-against-multi-faceted-inflammatory-targets
#25
JOURNAL ARTICLE
Sangeetha Mohan, Lekshmy Krishnan, Nithya Madhusoodanan, Anjali Sobha, Renjitha Jalaja, Alaganandam Kumaran, Naveen Vankadari, Jayamurthy Purushothaman, Sasidhar B Somappa
Prolonged inflammation leads to the genesis of various inflammatory diseases such as atherosclerosis, cancer, inflammatory bowel disease, Alzheimer's, etc. The uncontrolled inflammatory response is characterized by the excessive release of pro-inflammatory mediators such as nitric oxide (NO), tumor necrosis factor-alpha (TNF-α), interleukin-6 (IL-6), interleukin-1alpha (IL-1α), and inflammatory enzymes such as cyclooxygenase-2 (COX-2). Hence, the downregulation of these inflammatory mediators is an active therapy to control aberrant inflammation and tissue damage...
March 17, 2024: Journal of Agricultural and Food Chemistry
https://read.qxmd.com/read/38479543/mahuang-fuzi-xixin-decoction-alleviates-allergic-rhinitis-by-inhibiting-nlrp3-caspase-1-gsdmd-n-mediated-pyroptosis
#26
JOURNAL ARTICLE
Mengze Ding, Xiaohan Wei, Changshun Liu, Xiaomei Tan
ETHNOPHARMACOLOGICAL RELEVANCE: Allergic rhinitis (AR) is a prevalent nasal inflammatory disorder, and pyroptosis plays a crucial role in aggravating AR. Current medications for AR treatment still have deficiencies, and finding new agents is of great interest. Mahuang Fuzi Xixin decoction (MFXD), an ancient Chinese medicine, is now commonly used to treat AR, which has anti-inflammatory and immunomodulatory effects, but its underlying mechanism is unknown. AIM OF THIS STUDY: This study aims to evaluate the effects of MFXD on AR and explore its potential mechanisms in view of the regulatory effect on pyroptosis...
March 11, 2024: Journal of Ethnopharmacology
https://read.qxmd.com/read/38469896/platinum-nanoparticles-regulated-v-2-c-mxene-nanoplatforms-with-nir-ii-enhanced-nanozyme-effect-for-photothermal-and-chemodynamic-anti-infective-therapy
#27
JOURNAL ARTICLE
Xiaojun He, Ya Lv, Yanling Lin, Hong Yu, Yipiao Zhang, Yuhua Tong, Chunwu Zhang
Given the challenge of multidrug resistance in antibiotics, non-antibiotic-dependent antibacterial strategies show promise for anti-infective therapy. V2 C MXene-based nanomaterials have demonstrated strong biocompatibility and photothermal conversion efficiency (PCE) for photothermal therapy (PTT). However, the limitation of V2 C MXene's laser irradiation to the near-infrared region I (NIR-I) restricts tissue penetration, making it difficult to achieve complete bacterial eradication with single-effect therapeutic strategies...
March 12, 2024: Advanced Materials
https://read.qxmd.com/read/38467596/open-label-single-center-clinical-study-evaluating-the-safety-tolerability-and-clinical-effects-of-pentosan-polysulfate-sodium-in-subjects-with-mucopolysaccharidosis-i
#28
JOURNAL ARTICLE
Drago Bratkovic, Curtis Gravance, David Ketteridge, Ravi Krishnan, Divya Navuru, Michael Sheehan, Donna Skerrett, Michael Imperiale
Lysosomal enzyme deficiency in mucopolysaccharidosis (MPS) I results in glycosaminoglycan (GAG) accumulation leading to pain and limited physical function. Disease-modifying treatments for MPS I, enzyme replacement, and hematopoietic stem cell therapy (HSCT), do not completely resolve MPS I symptoms, particularly skeletal manifestations. The GAG reduction, anti-inflammatory, analgesic, and tissue remodeling properties of pentosan polysulfate sodium (PPS) may provide disease-modifying treatment for musculoskeletal symptoms and joint inflammation in MPS I following ERT and/or HSCT...
March 2024: Journal of Inherited Metabolic Disease
https://read.qxmd.com/read/38466073/aerosol-inhalation-of-inflammatory-cells-targeted-dendrimer-dexamethasone-conjugate-for-efficient-allergic-asthma-therapy
#29
JOURNAL ARTICLE
Danfei Chen, Xiaobo Xuan, Yuyan Chen, Xia Fang, Liwei Liu, Guowei Wang, Jian Chen
Allergic asthma (AA) is a common breathing disorder clinically characterized by the high occurrence of acute and continuous inflammation. However, the current treatment options for AA are lacking in effectiveness and diversity. In this study, we determined that the cell membrane receptor of gamma-glutamyl transferase (GGT) was highly overexpressed on the inflammatory cells that infiltrate the pulmonary tissues in AA cases. Therefore, we developed a GGT-specific dendrimer-dexamethasone conjugate (GSHDDC) that could be administered via aerosol inhalation to treat AA in a rapid and sustained manner...
March 1, 2024: Biointerphases
https://read.qxmd.com/read/38462750/preoperative-beta-blockers-and-other-drugs-in-relation-to-anastomotic-leakage-after-anterior-resection-for-rectal-cancer
#30
JOURNAL ARTICLE
Anders Gerdin, Jennifer Park, Jenny Häggström, Josefin Segelman, Peter Matthiessen, Marie-Louise Lydrup, Martin Rutegård
AIM: Previous research has indicated that preoperative beta blocker therapy is associated with a decreased risk of complications after surgery for rectal cancer. This is thought to arise because of the anti-inflammatory activity of the drug. These results need to be reproduced and analyses extended to other drugs with such properties, as this information might be useful in clinical decision-making. The main aim of this work was to replicate previous findings of beta blocker use as a prognostic marker for postoperative leakage...
March 10, 2024: Colorectal Disease
https://read.qxmd.com/read/38459498/comparison-between-stem-cell-therapy-and-stem-cell-derived-exosomes-on-induced-multiple-sclerosis-in-dogs
#31
JOURNAL ARTICLE
Ahmed N Abdallah, Ashraf A Shamaa, Omar S El-Tookhy, Mohamed M Bahr
BACKGROUND: Multiple sclerosis (MS) is a chronic condition that primarily manifests as demyelination of neuronal axons in the central nervous system, due to the loss or attack of oligodendroglia cells that form myelin. Stem cell therapy has shown promising results for the treatment of MS due to its capability to halt the immune attack, stop apoptosis and axonal degeneration, and differentiate into oligodendrocytes. Stem cell-derived Exosomes (Exosomes) have shown great capabilities for neuronal diseases as they have growth factors, complex sets of miRNA, enzymes, proteins, major peptides, lipids, and macromolecules with anti-inflammatory, angiogenesis, and neurogenesis activities...
March 8, 2024: BMC Veterinary Research
https://read.qxmd.com/read/38453668/discovery-structure-based-modification-in-vitro-in-vivo-and-in-silico-exploration-of-m-sulfamoyl-benzoamide-derivatives-as-selective-butyrylcholinesterase-inhibitors-for-treating-alzheimer-s-disease
#32
JOURNAL ARTICLE
Xin Lu, Yueqing Li, Qianwen Guan, Huajing Yang, Yijun Liu, Chenxi Du, Lei Wang, Qinghua Wang, Yuqiong Pei, Liang Wu, Haopeng Sun, Yao Chen
For the potential therapy of Alzheimer's disease (AD), butyrylcholinesterase (BChE) has gradually gained worldwide interest in the progression of AD. This study used a pharmacophore-based virtual screening (VS) approach to identify Z32439948 as a new BChE inhibitor. Aiding by molecular docking and molecular dynamics, essential binding information was disclosed. Specifically, a subpocket was found and structure-guided design of a series of novel compounds was conducted. Derivatives were evaluated in vitro for cholinesterase inhibition and physicochemical properties (BBB, log  P , and solubility)...
March 7, 2024: ACS Chemical Neuroscience
https://read.qxmd.com/read/38449453/effects-of-perilla-frutescens-var-acuta-in-busulfan-induced-spermatogenesis-dysfunction-mouse-model
#33
JOURNAL ARTICLE
Hyung Jong Nam, Min Jung Park, Bo Sun Joo, Yean Kyoung Koo, SukJin Kim, Sang Don Lee, Hyun Jun Park
PURPOSE: The leaves of Perilla frutescens var. acuta (PFA) are generally reported to have antioxidant, anti-allergic, anti-inflammatory, and antitumor effects and commonly used as a traditional medicine in East Asia. This study aimed to investigate the protective effect and antioxidant activity of PFA on busulfan-induced testicular dysfunction, histological damage, oxidative stress (OS), sperm quality, and hormone levels using a mouse model. MATERIALS AND METHODS: C57BL/6 male mice were divided into four groups: control, busulfan-only treated, and varying concentrations of PFA (100 and 200 mg/kg) with busulfan...
February 14, 2024: World Journal of Men's Health
https://read.qxmd.com/read/38447765/%C3%AE-keto-amyrin-isolated-from-cryptostegia-grandiflora-r-br-inhibits-inflammation-caused-by-daboia-russellii-viper-venom-direct-binding-of-%C3%AE-keto-amyrin-to-phospholipase-a-2
#34
JOURNAL ARTICLE
K H Santhosh, V Krishna, K Kemparaju, H Manjunatha, R Shashi Kumar, Mukherjee Arnab, S E Gomez Mejiba, D C Ramirez, B S Ravindranath
The search for mechanism-based anti-inflammatory therapies is of fundamental importance to avoid undesired off-target effects. Phospholipase A2 (PLA2 ) activity is a potential molecular target for anti-inflammatory drugs because it fuels arachidonic acid needed to synthesize inflammation mediators, such as prostaglandins. Herein, we aim to investigate the molecular mechanism by which β-keto amyrin isolated from a methanolic extract of Cryptostegia grandiflora R. Br. Leaves can inhibit inflammation caused by Daboia russellii viper (DR) venom that mainly contains PLA2 ...
March 4, 2024: Toxicon: Official Journal of the International Society on Toxinology
https://read.qxmd.com/read/38442929/-impact-of-extracorporeal-carbon-dioxide-removal-combined-with-continuous-renal-replacement-therapy-on-diaphragmatic-function-in-patients-with-acute-respiratory-distress-syndrome
#35
RANDOMIZED CONTROLLED TRIAL
Xingang Hu, Wenwen Zhang, Yafen Jiang, Jie Zhang, Zhida Liu, Cuijie Tian, Xuelin Wang, Jianjian Cheng
OBJECTIVE: To investigate the effects of extracorporeal carbon dioxide removal (ECCO2 R) combined with continuous renal replacement therapy (CRRT) on respiratory efficiency and diaphragm function in patients with acute respiratory distress syndrome (ARDS) received mechanical ventilation. METHODS: A prospective randomized controlled study was conducted. Sixty patients with mild to moderate ARDS admitted to the department of respiratory and critical care medicine of Henan Provincial People's Hospital from January 2019 to January 2021 were enrolled, and they were divided into observation group and control group according to the random number table method, with 30 cases in each group...
February 2024: Zhonghua Wei Zhong Bing Ji Jiu Yi Xue
https://read.qxmd.com/read/38441512/potency-assay-to-predict-the-anti-inflammatory-capacity-of-a-cell-therapy-product-for-macrophage-driven-diseases-overcoming-the-challenges-of-assay-development-and-validation
#36
JOURNAL ARTICLE
Samar Sadeghi, Laura Nimtz, Elke Niebergall-Roth, Alexandra Norrick, Stefan Hägele, Lena Vollmer, Jasmina Esterlechner, Markus H Frank, Christoph Ganss, Karin Scharffetter-Kochanek, Mark Andreas Kluth
BACKGROUND: Given the high level of product complexity and limited regulatory guidance, designing and implementing appropriate potency assays is often the most challenging part of establishing a quality control testing matrix for a cell-based medicinal product. Among the most elusive tasks are the selection of suitable read-out parameters, the development of assay designs that most closely model the pathophysiological conditions, and the validation of the methods. Here we describe these challenges and how they were addressed in developing an assay that measures the anti-inflammatory potency of mesenchymal stromal cells (MSCs) in an M1 macrophage-dominated inflammatory environment...
February 18, 2024: Cytotherapy
https://read.qxmd.com/read/38441190/micronutrients-as-therapy-in-critical-illness
#37
JOURNAL ARTICLE
Christian Stoppe, Ellen Dresen, Angelique de Man
PURPOSE OF REVIEW: Recent large-scale randomized controlled trials (RCTs) challenged current beliefs about the potential role of micronutrients to attenuate the inflammatory response and improve clinical outcomes of critically ill patients. The purpose of this narrative review is to provide an overview and critical discussion about most recent clinical trials, which evaluated the clinical significance of a vitamin C, vitamin D, or selenium administration in critically ill patients. RECENT FINDINGS: None of the most recent large-scale RCTs could demonstrate any clinical benefits for a micronutrient administration in ICU patients, whereas a recent RCT indicated harmful effects, if high dose vitamin C was administered in septic patients...
January 8, 2024: Current Opinion in Critical Care
https://read.qxmd.com/read/38440290/the-role-of-inflammatory-mediators-and-matrix-metalloproteinases-mmps-in-the-progression-of-osteoarthritis
#38
REVIEW
Anwesha Mukherjee, Bodhisatwa Das
Osteoarthritis (OA) is a chronic musculoskeletal disorder characterized by an imbalance between (synthesis) and catabolism (degradation) in altered homeostasis of articular cartilage mediated primarily by the innate immune system. OA degenerates the joints resulting in synovial hyperplasia, degradation of articular cartilage with damage of the structural and functional integrity of the cartilage extracellular matrix, subchondral sclerosis, osteophyte formation, and is characterized by chronic pain, stiffness, and loss of function...
March 2024: Biomater Biosyst
https://read.qxmd.com/read/38435190/etiology-of-drug-induced-edema-a-review-of-dihydropyridine-thiazolidinedione-and-other-medications-causing-edema
#39
REVIEW
Evan S Sinnathamby, Bretton T Urban, Robert A Clark, Logan T Roberts, Audrey J De Witt, Danielle M Wenger, Aya Mouhaffel, Olga Willett, Shahab Ahmadzadeh, Sahar Shekoohi, Alan D Kaye, Giustino Varrassi
Edema is an accumulation of fluid in the body's tissues that affects millions of Americans yearly. It can affect multiple body parts, for example, the brain or eyes, but often occurs in the periphery, including the feet and legs. Medications, such as dihydropyridine and thiazolidinediones (TZDs), can be the etiology of edema. Edema can develop in association with problems in the vasculature or lymphatic flow. In recent years, a better understanding of these drug-induced mechanisms has been appreciated. Specifically, dihydropyridines can increase hydrostatic pressure and cause selective pre-capillary vessel vasodilation...
February 2024: Curēus
https://read.qxmd.com/read/38430455/neutrophilic-activity-biomarkers-plasma-neutrophil-extracellular-traps-and-calprotectin-in-established-patients-with-rheumatoid-arthritis-receiving-biological-or-jak-inhibitors-a-clinical-and-ultrasonographic-study
#40
JOURNAL ARTICLE
Beatriz Frade-Sosa, Andrés Ponce, Estíbaliz Ruiz-Ortiz, Noemí De Moner, María J Gómara, Ana Belén Azuaga, Juan C Sarmiento-Monroy, Rosa Morlà, Virginia Ruiz-Esquide, Laura Macías, Nuria Sapena, Lola Tobalina, Julio Ramirez, Juan D Cañete, Jordi Yague, Josep M Auge, José A Gomez-Puerta, Odette Viñas, Isabel Haro, Raimon Sanmarti
INTRODUCTION: This study assesses the accuracy of neutrophil activation markers, including neutrophil extracellular traps (NETs) and calprotectin, as biomarkers of disease activity in patients with established rheumatoid arthritis (RA). We also analyse the relationship between NETs and various types of therapies as well as their association with autoimmunity. METHODS: Observational cross-sectional study of patients with RA receiving treatment with biological disease-modifying antirheumatic drugs or Janus kinase inhibitors (JAK-inhibitors) for at least 3 months...
March 2, 2024: Rheumatology and Therapy
keyword
keyword
64889
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.